Professor of Health Economics & Director, HERC
- Professor of Health Economics, University of Oxford
- Academic, Melbourne School of Population and Global Health
- Honorary, Melbourne Institute of Applied Economic and Social Research
Professor Philip Clarke re-joined HERC in August 2018 after previous appointments at the Universities of Sydney and Melbourne in Australia. He is a Fellow of the Academy of the Social Sciences in Australia (ASSA).
His research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. Philip has been involved in the development of the UKPDS Outcomes Model, a health economic simulation model for type 2 diabetes.
How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton.
Roope LSJ. et al, (2020), Pharmacoecon Open
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge.
Si L. et al, (2020), Value Health, 23, 1163 - 1170
Survival, dependency and health-related quality of life in patients with ruptured intracranial aneurysm: ten-year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT)
HUA X. et al, (2020), Neurosurgery
Patient-reported outcome measures (PROMs): can they be used to guide patient-centered care and optimize outcomes in total knee replacement?
Tew M. et al, (2020), Qual Life Res
Effects of Allopurinol on the Progression of Chronic Kidney Disease.
Badve SV. et al, (2020), N Engl J Med, 382, 2504 - 2513